Table 1 of Cehofski, Mol Vis 2024; 30:17-35.


Table 1. Samples for proteomic analysis.

Various DME Control p-value
Number of samples (n) 13* 11  
Patients (n) 11    
Age (years) 61.9±18.7 68.5±11.3 0.32
Sex (M/F) 5/8 5/6  
BCVA (logMAR) 0.48±0.25    
Central subfield thickness (µm) 366.9±176.0    
Mild non-proliferative diabetic retinopathy (n) 1    
Moderate non-proliferative diabetic retinopathy (n) 3    
Severe non-proliferative diabetic retinopathy (n) 3    
Proliferative diabetic retinopathy (n) 6    
HbA1c (%) 8.1±2.0    
Hypertension (n) 10 2 0.012
Hyperlipidemia (n) 6 2 0.21
Oral treatment (n) 11    
Oral treatment and insulin (n) 4    
Insulin, no oral treatment (n) 0    
Creatinin mg/dl 1.71±1.37 0.76±0.15 0.023